| | the
Group and its Affiliates involve themselves. All releases are disseminated broadly
and simultaneously pursuant to the rules and regulations of the Swiss and New
York Stock Exchanges. Press releases relating to financial results and material
events are also filed with the SEC under Form 6-K. An archive containing Annual
Reports to Shareholders, annual reports to the SEC on Form 20-F, and quarterly
results releases as well as related materials, such as slide presentations and
conference call webcasts, can be found on the Novartis Investor Relations website
(www.novartis.com/investors) and is accessible to anyone, irrespective of whether
or not that person is a shareholder. A press release archive is maintained on
the Novartis website at: www.novartis.com/news/en/media.shtml
Information contained in all reports and releases is deemed correct and accurate
at the time of release. Novartis does not update past releases to take into account
changes in the marketplace or our businesses.
INVESTOR RELATIONS PROGRAM Novartis runs an Investor
Relations program, which includes the following:
| • | A
Full-Year Results presentation; | | • | Investor
Events focusing on the Novartis Pharmaceutical Pipeline; | | • | Themed
events, covering areas of interest such as therapeutic advances in medicine, pharmaceutical
research or the generics business (Sandoz); | | • | One-on-one
and group meetings with Investors and Analysts at a Novartis site or during roadshows
at major financial centers; | | • |
Conference calls for quarterly results or in conjunction with other press releases; | | • | Presentations
at broker-sponsored industry conferences. |
These
activities focus on recently announced activities or financial results and are
conducted in line with stock exchange disclosure rules and Regulation FD. | | Presentations
to the financial community are regularly posted in an archive on the Investor
Relations website, as audio webcasts and/or pdf documents for slide presentations.
These presentations are not regularly updated, but reflect the developments within
the company over time. Novartis Investor Relations
is managed out of headquarters in Basel, Switzerland. A team of professionals
is located in New York to assist in coordinating responses to inquiries from the
US. Their contact details as well as an Investor Relations mailbox are made available
on the Novartis Investor Relations website (www.novartis.com/investors).
Through
the Internet there is also an opportunity to sign up for the Investor Relations
e-mail distribution system.
PERFORMANCE GRAPH
This graph compares our total shareholder returns,
the Morgan Stanley World Pharmaceuticals Index (MSWPI), and the Swiss Market Index
(SMI). The graph assumes CHF 100 invested in Novartis at the closing price on
December 31, 1995 – and an equal amount invested in each of the indices.  | |
